Zijian Zhang

Statistics

Publications

Citations

151

H-Index

Active since

2018

Affiliations

Wuhan University of Science and Technology(Current)

Wuhan University

Zhongnan Hospital of Wuhan University

Wuchang University of Technology

Tianjin University of Science and Technology

Zijian Zhang is an author at Wuhan University of Science and Technology specializing in oncology, car t-cell exhaustion, and antitumor t cell responses.

ORCID

Publications per year

2018–2025

Publications

Hyperoside and let-7a-5p synergistically inhibits lung cancer cell proliferation via inducing G1/S phase arrest

Jia‐Peng Li, Xing‐Hua Liao, Ao Yao et al. · Gene · 2018 · 52 citations

Medicine, Oncology, Pharmacology +12

The third-generation anti-CD30 CAR T-cells specifically homing to the tumor and mediating powerful antitumor activity

Shangkun Zhang, Chaojiang Gu, Lifang Huang et al. · Scientific Reports · 2022 · 36 citations · Full text

Life Sciences, Immunology, Oncology +17

Targeting the TRIM21-PD-1 axis potentiates immune checkpoint blockade and CAR-T cell therapy

Jie Shi, Zijian Zhang, Hsin-Yi Chen et al. · Molecular Therapy · 2025 · 17 citations · Full text

Medicine, Immunology, Oncology +16

ATF4 renders human T-cell acute lymphoblastic leukemia cell resistance to FGFR1 inhibitors through amino acid metabolic reprogramming

Zijian Zhang, Qifang Wu, Anqi Ren et al. · Acta Pharmacologica Sinica · 2023 · 14 citations · Full text

Medicine, Cancer Biology, Oncology +12

Serine/threonine/tyrosine kinase 1 drives pancreatic carcinogenesis via GSK3β sequestration-mediated Wnt/β-catenin pathway hyperactivation

Cefan Zhou, Xueying Dong, Shi Li et al. · Signal Transduction and Targeted Therapy · 2025 · 12 citations · Full text

Medicine, Molecular Biology, Oncology +17

1–5 of 7